Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

43.71
Delayed Data
As of Nov 23
 +0.10 / +0.23%
Today’s Change
38.40
Today|||52-Week Range
67.88
-29.25%
Year-to-Date

Today’s Trading

Previous close43.57
Today’s open44.26
Day’s range43.24 - 45.14
Volume112,872
Average volume (3 months)166,935
Market cap$875.3M
Data as of 3:59pm ET, 11/23/2020

Growth & Valuation

Earnings growth (last year)-36.62%
Earnings growth (this year)-158.76%
Earnings growth (next 5 years)-83.30%
Revenue growth (last year)-0.69%
P/E ratio437.1
Price/Sales6.14
Price/Book1.86

Competitors

 Today’s
change
Today’s
% change
AMPHAmphastar Pharmaceut...-0.44-2.40%
CLLSCellectis SA+0.96+4.54%
TCRRTCR2 Therapeutics In...-0.81-2.98%
KRYSKrystal Biotech Inc+2.00+4.74%
Data as of 3:59pm ET, 11/23/2020

Financials

Next reporting dateFebruary 10, 2021
EPS forecast (this quarter)-$0.85
Annual revenue (last year)$205.2M
Annual profit (last year)$46.4M
Net profit margin22.60%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Watertown, Massachusetts

Forecasts